The long-term outcomes of sleeve gastrectomy (SG) and Roux-en-Y gastric bypass (RYGB) may differ in intention-to-treat ...
Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate ...
A new study published in the Journal of American Medical Association focusing on Swiss Multicenter Bypass or Sleeve Study ...
Learn about gastric cancer in India, its causes, early detection methods, and treatment options, including the role of diet, ...
Adults with obesity who underwent Roux-en-Y gastric bypass achieved a greater excess BMI loss at 10 years compared with those ...
The following is a summary of “Prognostic performance of examined lymph nodes, lymph node ratio, and positive lymph nodes in ...
Signet Therapeutics, a clinical-stage biotech company leveraging organoid- and AI-driven cancer drug discovery, announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track ...
Acid reducing medicines from the group of proton pump inhibitors (PPIs) are best-selling drugs that prevent and alleviate stomach problems. PPIs are activated in the acid-producing cells of the ...
Agenus Inc. (Nasdaq: AGEN), a leader in immuno-oncology, today presented data at the American Association for Cancer Research (AACR) IO Annual Meeting in Los Angeles, California. The oral presentation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback